Tired-eye supplement introduced at the American Optometric Association

Article

At the recent American Optometric Association annual congress, Astavita Professional introduced astaxanthin (AstaREAL, Fuji Health Science) for the relief and prevention of asthenopia.

Key Points

Burlington, NJ-At the recent American Optometric Association annual congress, Astavita Professional introduced astaxanthin (AstaREAL, Fuji Health Science) for the relief and prevention of asthenopia.

Asthenopia is characterized by sensitivity to glare, headaches, sore eyes, and blurred vision. Fuji Chemical Industry of Japan's 11 human clinical studies of an all-natural antioxidant-astaxanthin-have shown significant positive results against asthenopia.

Astaxanthin acts as both a lipid-soluble and water-soluble antioxidant to reduce cellular inflammation while protecting cells. Supporting studies have shown that astaxanthin increases capillary blood flow and improves ciliary body function, as well as increases the endurance and recovery of muscles after overuse, exercise, and other forms of stress.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.